Free Sample Reports

14 Results (Page 1 of 2)

Australia Free Sample Markets Research Reports

Pharmaceuticals

Australia Dermatology Drugs Market Sample Report

By 2030, it is anticipated that the Australia dermatology drugs market will reach a value of $516 Mn from $204 Mn in 2022, growing at a CAGR of 12.3% during 2022-2030. The market is primarily dominated by local players such as Faulding, Bioscience International, Aspen Pharmacare, and Alpha pharm. The market is driven by an aging population, disparities in universal health coverage, and the launch of new and innovative drugs. This market is segmented by drug class, drug type, prescription mode, indication, route of administration, end-user, and distribution channel.

LAST UPDATED: Jan, 2024

Pharmaceuticals

Australia Antibacterial (Antibiotics) Drugs Market Analysis Sample Report

This report presents a strategic analysis of the Australia Antibacterial (Antibiotics) Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Australian antibacterial (Antibiotics) Drugs Market, offering unmatched value, accuracy, and expert insights.

LAST UPDATED: Nov, 2023

Pharmaceuticals

Australia Alzheimer's Disease Market Analysis Sample Report

The growing prevalence of Alzheimer's disease in elderly women in Australia is responsible for the growth of Australia Alzheimer's disease market. The market is segmented by product, drug, and distribution channel. Roche, Eisai, and Novartis are some of the key competitors in the market.

LAST UPDATED: Oct, 2023

Pharmaceuticals

Australia Oral Care Market Analysis Sample Report

Australia's Oral Care market was valued at $423 Mn in 2022 and is estimated to expand at a CAGR of 7.7% from 2022 to 2030 and will reach $765 Mn in 2030. One of the main reasons propelling the growth of this market is Increasing Disposable Income and the ageing population. The market is segmented by type, drug, and distribution channel. Some key players in this market are White Glo, Grants of Australia, Red Seal, Dr. Brite, and Pure Smile among others.

LAST UPDATED: Aug, 2023

Pharmaceuticals

Australia Acne Therapeutics Market Analysis Sample Report

Australia's acne therapeutics market is expected to grow from $120 Mn in 2022 to $226 Mn in 2030 with a CAGR of 8.2% for the forecasted year 2022-2030. More than 90% of Australian teenagers suffer from acne vulgaris which leads to the increasing demand for acne treatment options in Australia thereby driving the growth of Australia's acne therapeutics market. The market is segmented by treatment, route of administration, age group, and by distribution channel. Some of the major players in the Australian acne therapeutics market are Sypharma, BioDiem, and Novan.

LAST UPDATED: Jul, 2023

Healthcare Services

Australia Home Healthcare Market Analysis Sample Report

Australia home healthcare market is projected to grow from $4.35 Bn in 2022 to $8.94 Bn in 2030 with a CAGR of 9.43% for the year 2022-2030. The market has witnessed significant growth post-pandemic. The market is segmented by product, service, software, and by region.

LAST UPDATED: Jul, 2023

Pharmaceuticals

Australia Lung Cancer Drugs Market Analysis Sample Report

Lung cancer is the fifth most common type of cancer affecting the Australian population, therefore the Australia lung cancer drugs market is projected to grow during the forecast period. The market is segmented by type, treatment, end user, route of administration, and distribution channel.

LAST UPDATED: Feb, 2023

OTC & Nutraceuticals

Australia OTC Drugs Market Analysis Sample Report

Australia Over The Counter (OTC) drugs market is projected to grow from $2.04 Bn in 2022 to $3.95 Bn in 2030 with a CAGR of 8.6% for the year 2022-2030. Major OTC innovation trends include treatment based, lifestyle based, format based and extended offering. The market is segmented by drug type and by distribution channel.

LAST UPDATED: Feb, 2023

Rare Diseases

Australia Primary Hyperoxaluria (PH) Market Analysis Sample Report

Australia Primary Hyperoxaluria (PH) market stood at around $2.1 Mn in 2022 and is projected to reach $8.8 Mn with a CAGR of 19% for the year 2022-2030. The market is segmented by type, diagnosis, drug, treatment and by distribution channel. Alnylam Pharmaceuticals and Dicerna Pharmaceuticals are some of the key players in the Australia PH market.

LAST UPDATED: Feb, 2023

Rare Diseases

Australia Sickle Cell Disease Market Analysis Sample Report

Australia Sickle Cell Disease market is expected to grow from $1.1 Mn in 2022 to $2.6 Mn in 2030 with a CAGR of 11% for the year 2022 to 2030. The market is segmented by treatment modality and by distribution channel. Novartis and AstraZeneca are some of the key players in the Australia sickle cell disease market.

LAST UPDATED: Feb, 2023

Healthcare Services

Australia Physiotherapy Market Analysis Sample Report

The Australia physiotherapy market is expected to witness growth from $638 Mn in 2022 to $1,126 Mn in 2030 with a CAGR of 7.35% for the year 2022-2030. Arthritis, osteoporosis and back pain are the major conditions that require physiotherapy. The market is segmented by treatments and conditions.

LAST UPDATED: Feb, 2023

Healthcare Services

Australia Patient Support Program Market Analysis Sample Report

Patient Support Programs (PSP) in Australia provide patients with significant value through the accessibility of information and support during and after the course of their treatment, therefore, leading to the growth of Australia patient support programs. Pharmaceutical companies sponsored PSPs are designed to aid compliance and lifestyle choices.

LAST UPDATED: Feb, 2023

subscribe to our newsletter
up